Written by: Jonine Möller, M.Sc. in Sport Science
The ACTN3 gene, also known as the "sprinter gene," has been the subject of much research in the field of sports science. This gene is believed to play a key role in determining athletic power and sports performance potential.
ACTN3 codes for a protein called alpha-actinin-3, which is found in fast-twitch muscle fibers. These fibers are responsible for generating quick, powerful movements such as sprinting, jumping, and weightlifting. On the other hand, slow-twitch fibers are used for endurance activities like running and cycling.
Studies have shown that the ACTN3 gene comes in two variants: R (arginine) and X (glutamine). Individuals with the R variant produce more alpha-actinin-3, which gives them an advantage in power-based activities.
On the other hand, those with the X variant have a greater capacity for endurance activities. The X variant causes a premature stop codon in the gene code for the alpha-actinin-3 protein. Thus, individuals with the XX genotype have a deficiency in this protein, a lower percentage of type 2 muscle fibres and thus lower strength, speed and power.
It's important to note that the presence of the R or X variant does not guarantee success in a particular sport. Many other factors, including training, nutrition, and psychological factors, also play a crucial role in athletic performance. However, ACTN3 is one of the few genetic factors that have been consistently linked to differences in athletic ability.
In conclusion, the ACTN3 gene influences athletic power and sports performance potential by determining the type and quantity of muscle fibers an individual has. While it's just one piece of the puzzle, understanding the role of ACTN3 can help individuals make informed decisions about the types of physical activity they may be best suited for.
Interested in trying the BioCertica Fitness DNA kit? Click here and add Fitness to your cart for only R1699.
If you own any other BioCertica DNA kit, you can instantly unlock your Fitness results for only R599* in-app.
*Terms and conditions apply: Pharmacogenetics results are R1999 in-app.